2m 2m 2m 2m 2m 2m 2m
NRX PHARMA (NRXP)
NASDAQ
$4.10-$0.05 (-1.18%)
Price as of Jul 14, 2026 7:01 AM EDT- $177.6MMarket Cap
- 29.28%1-Year Change
- BiotechnologyIndustry
NRX PHARMA (NRXP)
$4.10-$0.05 (-1.18%)
NRXP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.15 | ||
Change | -$0.04 (-0.95%) | ||
Open | $4.17 | ||
High | $4.21 | ||
Low | $3.99 | ||
Previous Close | $4.19 | ||
Volume | 817,748 | ||
30-Day Average Volume | 915,289 | ||
1-Week Change | 5.20% | ||
1-Month Change | 8.07% | ||
1-Year Change | 29.28% | ||
3-Year Change | 4.01% | ||
5-Year Change | -96.17% | ||
Fundamentals | |||
Shares Outstanding | 42.8M | ||
Total Assets | $11.9M | ||
Market Cap | $177.6M | ||
Enterprise Value | $170.9M | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$1.4M | ||
Free Cash Flow | -$4.3M | ||
EBIT | -$1.4M | ||
EBITDA | -$1.4M | ||
Net Working Capital | -$17.8M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -125 | ||
Enterprise Value/Revenue | 160 | ||
P/B | -13 | ||
P/E | -104 | ||
PEG | -1 | ||
Price/Free Cash Flow | -41 | ||
Price/Operating Cash Flow | -41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/02/2024 | ||
Earnings & Revenue